MOPA help to plan the PR 2019 for “Contoura Vision” in China, as Alcon requested through another agency.
Contoura® Vision is topography-guided LASIK treatment by Alcon, who is the the global leader in eye care and a division of Novartis. MOPA help to plan the PR 2019 for “Contoura Vision” in China, as Alcon requested through another agency. Contoura Vision is a topography-guided LASIK treatment designed to provide surgeons the ability to perform more personalized laser procedures for patients with nearsightedness, or nearsightedness with astigmatism, based on the unique corneal topography of each eye. In 2014, more than 630,000 LASIK procedures were performed in the US alone.
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
Media,
|